Indeks št.
|
Kemijsko ime
|
Št. ES
|
Št. CAS
|
Razvrstitev
|
Označitev
|
Posebne mejne koncentracije, M-faktorji in ATE
|
Opombe
|
Razred nevarnosti in oznaka(-e) kategorije
|
Oznaka(-e) stavka o nevarnosti
|
Piktogram, oznaka(-e) opozorilne besede
|
Oznaka(-e) stavka o nevarnosti
|
Dod. oznaka(-e) stavka o nevarnosti
|
„005-007-00-2
|
borova kislina [1]
borova kislina [2]
|
233-139-2 [1]
234-343-4 [2]
|
10043-35-3 [1]
11113-50-1 [2]
|
Repr. 1B
|
H360FD
|
GHS08
Dgr
|
H360FD“
|
|
|
|
„005-008-00-8
|
diborov trioksid
|
215-125-8
|
1303-86-2
|
Repr. 1B
|
H360FD
|
GHS08
Dgr
|
H360FD“
|
|
|
|
„005-011-00-4
|
tetrabor-dinatrijev heptaoksid, hidrat; [1]
dinatrijev tetraborat, brezvodni; [2]
ortoborova kislina, natrijeva sol [3]
dinatrijev tetraborat dekahidrat [4]
dinatrijev tetraborat pentahidrat [5]
|
235-541-3 [1]
215-540-4 [2]
237-560-2 [3]
215-540-4 [4]
215-540-4 [5]
|
12267-73-1 [1]
1330-43-4 [2]
13840-56-7 [3]
1303-96-4 [4]
12179-04-3 [5]
|
Repr. 1B
|
H360FD
|
GHS08
Dgr
|
H360FD“
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
„006-069-00-3
|
tiofanat-metil (ISO);
dimetil (1,2-fenilendikarbamotioil)biskarbamat;
dimetil 4,4′-(o-fenilen)bis(3-tioalofanat)
|
245-740-7
|
23564-05-8
|
Carc. 2
Muta. 2
Acute Tox. 4
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H351
H341
H332
H317
H400
H410
|
GHS08
GHS07
GHS09
Wng
|
H351
H341
H332
H317
H410
|
|
vdihavanje: ATE = 1,7 mg/l
(prah in meglice)
M = 10
M = 10“
|
|
„006-076-00-1
|
mankozeb (ISO); manganov etilenbis(ditiokarbamat) (polimerni) kompleks s cinkovo soljo
|
–
|
8018-01-7
|
Carc. 2
Repr. 1B
STOT RE 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H351
H360D
H373 (ščitnica, živčni sistem)
H317
H400
H410
|
GHS08
GHS07
GHS09
Dgr
|
H351
H360D
H373 (ščitnica, živčni sistem)
H317
H410
|
|
M = 10
M = 10“
|
|
„015-113-00-0
|
tolklofos-metil (ISO);
O-(2,6-dikloro-p-tolil) O,O-dimetil tiofosfat
|
260-515-3
|
57018-04-9
|
Skin Sens. 1B
Aquatic Acute 1
Aquatic Chronic 1
|
H317
H400
H410
|
GHS07
GHS09
Wng
|
H317
H410
|
|
M = 1
M = 1“
|
|
„028-007-00-4
|
trinikljev disulfid;
nikljev subsulfid; [1]
heazlewoodit [2]
|
234-829-6 [1]
– [2]
|
12035-72-2 [1]
12035-71-1 [2]
|
Carc. 1A
Muta. 2
Acute Tox. 3
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H350i
H341
H331
H372**
H317
H400
H410
|
GHS08
GHS06
GHS09
Dgr
|
H350i
H341
H331
H372**
H317
H410
|
|
vdihavanje:
ATE = 0,92 mg/l
(prah ali meglice)“
|
|
„029-002-00-X
|
dibakrov oksid;
bakrov (I) oksid
|
215-270-7
|
1317-39-1
|
Acute Tox. 4
Acute Tox. 4
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H332
H302
H318
H400
H410
|
GHS07
GHS05
GHS09
Dgr
|
H332
H302
H318
H410
|
|
vdihavanje: ATE = 3,34 mg/l (prah ali meglice)
oralno: ATE = 500 mg/kg tt
M = 100
M = 10“
|
|
„029-015-00-0
|
bakrov tiocianat
|
214-183-1
|
1111-67-7
|
Aquatic Acute 1
Aquatic Chronic 1
|
H400
H410
|
GHS09
Wng
|
H410
|
EUH032
|
M = 10
M = 10“
|
|
„029-016-00-6
|
bakrov (II) oksid
|
215-269-1
|
1317-38-0
|
Aquatic Acute 1
Aquatic Chronic 1
|
H400
H410
|
GHS09
Wng
|
H410
|
|
M = 100
M = 10“
|
|
„029-017-00-1
|
dibakrov klorid trihidroksid
|
215-572-9
|
1332-65-6
|
Acute Tox. 4
Acute Tox. 3
Aquatic Acute 1
Aquatic Chronic 1
|
H332
H301
H400
H410
|
GHS06
GHS09
Dgr
|
H332
H301
H410
|
|
vdihavanje: ATE = 2,83 mg/l (prah ali meglice)
oralno: ATE = 299 mg/kg tt
M = 10
M = 10“
|
|
„029-018-00-7
|
tetrabakrov heksahidroksid sulfat; [1]
tetrabakrov heksahidroksid sulfat hidrat [2]
|
215-582-3 [1]
215-582-3 [2]
|
1333-22-8 [1]
12527-76-3 [2]
|
Acute Tox. 4
Aquatic Acute 1
Aquatic Chronic 1
|
H302
H400
H410
|
GHS07
GHS09
Wng
|
H302
H410
|
|
oralno: ATE = 500 mg/kg tt
M = 10
M = 10“
|
|
„029-019-01-X
|
bakrove luske (prevlečene z alifatskimi kislinami)
|
–
|
–
|
Acute Tox. 3
Acute Tox. 4
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
|
H331
H302
H319
H400
H410
|
GHS06
GHS09
Dgr
|
H331
H302
H319
H410
|
|
vdihavanje: ATE = 0,733 mg/l (prah ali meglice)
oralno: ATE = 500 mg/kg tt
M = 10
M = 10“
|
|
„029-020-00-8
|
bakrov (II) karbonat--bakrov (II) hidroksid (1:1)
|
235-113-6
|
12069-69-1
|
Acute Tox. 4
Acute Tox. 4
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
|
H332
H302
H319
H400
H410
|
GHS07
GHS09
Wng
|
H332
H302
H319
H410
|
|
vdihavanje: ATE = 1,2 mg/l (prah ali meglice)
oralno: ATE = 500 mg/kg tt
M = 10
M = 10“
|
|
„029-021-00-3
|
bakrov dihidroksid;
bakrov (II) hidroksid
|
243-815-9
|
20427-59-2
|
Acute Tox. 2
Acute Tox. 4
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H330
H302
H318
H400
H410
|
GHS06
GHS05
GHS09
Dgr
|
H330
H302
H318
H410
|
|
vdihavanje: ATE = 0,47 mg/l (prah ali meglice)
oralno: ATE = 500 mg/kg tt
M = 10
M = 10“
|
|
„029-022-00-9
|
bordojska mešanica;
reakcijski produkti bakrovega sulfata s kalcijevim dihidroksidom
|
–
|
8011-63-0
|
Acute Tox. 4
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H332
H318
H400
H410
|
GHS07
GHS05
GHS09
Dgr
|
H332
H318
H410
|
|
vdihavanje: ATE = 1,97 mg/l (prah ali meglice)
M = 10
M = 1“
|
|
„029-023-00-4
|
bakrov sulfat pentahidrat
|
231-847-6
|
7758-99-8
|
Acute Tox. 4
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H302
H318
H400
H410
|
GHS07
GHS05
GHS09
Dgr
|
H302
H318
H410
|
|
oralno: ATE = 481 mg/kg tt
M = 10
M = 1“
|
|
„601-029-00-7
|
dipenten
limonen [1]
(S)-p-menta-1,8-dien; l-limonen [2]
trans-1-metil-4-(1-metilvinil)cikloheksen; [3]
(±)-1-metil-4-(1-metilvinil)cikloheksen [4]
|
205-341-0 [1]
227-815-6 [2]
229-977-3 [3]
231-732-0 [4]
|
138-86-3 [1]
5989-54-8 [2]
6876-12-6 [3]
7705-14-8 [4]
|
Flam. Liq. 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H226
H315
H317
H400
H410
|
GHS02
GHS07
GHS09
Wng
|
H226
H315
H317
H410
|
|
|
C“
|
„601-096-00-2
|
(R)-p-menta-1,8-dien;
d-limonen
|
227-813-5
|
5989-27-5
|
Flam. Liq. 3
Skin Irrit. 2
Skin Sens. 1B
Asp. Tox. 1
Aquatic Acute 1
Aquatic Chronic 3
|
H226
H315
H317
H304
H400
H412
|
GHS02
GHS07
GHS08
GHS09
Dgr
|
H226
H315
H317
H304
H410
|
|
M = 1“
|
|
„603-024-00-5
|
1,4-dioksan
|
204-661-8
|
123-91-1
|
Flam. Liq. 2
Carc. 1B
STOT SE 3
Eye Irrit. 2
|
H225
H350
H335
H319
|
GHS02
GHS08
GHS07
Dgr
|
H225
H350
H335
H319
|
EUH019
EUH066
|
|
D“
|
„603-066-00-4
|
7-oksa-3-oksiranilbiciklo[4.1.0]heptan; 1,2-epoksi-4-epoksietilcikloheksan; 4-vinilcikloheksen diepoksid
|
203-437-7
|
106-87-6
|
Carc. 1B
Muta. 2
Repr. 1B
Acute Tox. 3
Acute Tox. 4
|
H350
H341
H360F
H331
H302
|
GHS08
GHS06
Dgr
|
H350
H341
H360F
H331
H302
|
|
vdihavanje: ATE = 0,5 mg/l (prah ali meglice)
oralno: ATE = 1 847 mg/kg tt“
|
|
„603-098-00-9
|
2-fenoksietanol
|
204-589-7
|
122-99-6
|
Acute Tox. 4
STOT SE 3
Eye Dam. 1
|
H302
H335
H318
|
GHS05
GHS07
Dgr
|
H302
H335
H318
|
|
oralno:
ATE = 1 394 mg/kg tt“
|
|
„606-004-00-4
|
4-metilpentan-2-on; izobutil metil keton
|
203-550-1
|
108-10-1
|
Flam. Liq. 2
Carc. 2
Acute Tox. 4
STOT SE 3
Eye Irrit. 2
|
H225
H351
H332
H336
H319
|
GHS02
GHS07
GHS08
Dgr
|
H225
H351
H332
H336
H319
|
EUH066
|
vdihavanje: ATE = 11 mg/l (hlapi)“
|
|
„607-421-00-4
|
cipermetrin (ISO);
α-ciano-3-fenoksibenzil 3-(2,2-diklorovinil)-2,2-dimetilciklopropankarboksilat; cipermetrin cis/trans +/– 40/60
|
257-842-9
|
52315-07-8
|
Acute Tox. 4
Acute Tox. 4
STOT SE 3
STOT RE 2
Aquatic Acute 1
Aquatic Chronic 1
|
H332
H302
H335
H373 (živčni sistem)
H400
H410
|
GHS07
GHS08
GHS09
Wng
|
H332
H302
H335
H373 (živčni sistem)
H410
|
|
oralno; ATE = 500 mg/kg tt
vdihavanje; ATE = 3,3 mg/l (prah ali meglice)
M = 100000
M = 100000“
|
|
„607-424-00-0
|
trifloksistrobin (ISO); metil (E)-metoksiimino-{(E)-α-[1-(α,α,α-trifluoro-m-tolil)etilidenaminooksi]-o-tolil}acetat
|
–
|
141517-21-7
|
Lact.
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H362
H317
H400
H410
|
GHS07
GHS09
Wng
|
H362
H317
H410
|
|
M = 100
M = 10“
|
|
„607-434-00-5
|
mekoprop-P (ISO) [1] in njegove soli;
(R)-2-(4-kloro-2-metilfenoksi)propionska kislina [1] in njene soli;
|
240-539-0 [1]
|
16484-77-8 [1]
|
Acute Tox. 4
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H302
H318
H400
H410
|
GHS07
GHS05
GHS09
Dgr
|
H302
H318
H410
|
|
oralno: ATE = 431 mg/kg tt
M = 10
M = 10“
|
|
„608-058-00-4
|
esfenvalerat (ISO);
(S)-α-ciano-3-fenoksibenzil-(S)-2-(4-klorofenil)-3-metilbutirat
|
–
|
66230-04-4
|
Acute Tox. 3
Acute Tox. 3
STOT SE 1
STOT RE 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H331
H301
H370 (živčni sistem)
H373
H317
H400
H410
|
GHS06
GHS08
GHS09
Dgr
|
H331
H301
H370 (živčni sistem)
H373
H317
H410
|
|
oralno; ATE = 88,5 mg/kg tt
vdihavanje; ATE = 0,53 mg/l (prah ali meglice)
M = 10 000
M = 10 000 “
|
|
„612-067-00-9
|
3-aminometil-3,5,5-trimetilcikloheksilamin
|
220-666-8
|
2855-13-2
|
Acute Tox. 4
Skin Corr. 1B
Eye Dam. 1
Skin Sens. 1A
|
H302
H314
H318
H317
|
GHS05
GHS07
Dgr
|
H302
H314
H317
|
|
oralno: ATE = 1 030 mg/kg tt
Skin Sens. 1A; H317: C ≥ 0,001 %“
|
|
„612-252-00-4
|
imidakloprid (ISO);
(E)-1-(6-kloro-3-piridilmetil)-N-nitroimidazolidin-2-ilideneamin;
(2E)-1-[(6-kloropiridin-3-il)metil]-N-nitroimidazolidin-2-imin
|
428-040-8
|
138261-41-3
|
Acute Tox. 3
Aquatic Acute 1
Aquatic Chronic 1
|
H301
H400
H410
|
GHS06
GHS09
Dgr
|
H301
H410
|
|
oralno: ATE = 131 mg/kg tt
M = 100
M = 1 000 “
|
|
„613-048-00-8
|
karbendazim (ISO); metil benzimidazol-2-ilkarbamat
|
234-232-0
|
10605-21-7
|
Muta. 1B
Repr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H340
H360FD
H317
H400
H410
|
GHS07
GHS08
GHS09
Dgr
|
H340
H360FD
H317
H410
|
|
M = 10
M = 10“
|
|
„613-102-00-0
|
dimetomorf (ISO); (E,Z)-4-(3-(4-klorofenil)-3-(3,4-dimetoksifenil)akriloil)morfolin
|
404-200-2
|
110488-70-5
|
Repr. 1B
Aquatic Chronic 2
|
H360F
H411
|
GHS08
GHS09
Dgr
|
H360F
H411“
|
|
|
|
„613-111-00-X
|
1,2,4-triazol
|
206-022-9
|
288-88-0
|
Repr. 1B
Acute Tox. 4
Eye Irrit. 2
|
H360FD
H302
H319
|
GHS08
GHS07
Dgr
|
H360FD
H302
H319
|
|
oralno: ATE = 1 320 mg/kg tt“
|
|
„613-166-00-X
|
flumioksazin (ISO);
N-(7-fluoro-3,4-dihidro-3-okso-4-prop-2-inil-2H-1,4-benzoksazin-6-il)cikloheks-1-en-1,2-dikarboksimid
|
–
|
103361-09-7
|
Repr. 2
Aquatic Acute 1
Aquatic Chronic 1
|
H361d
H400
H410
|
GHS08
GHS09
Wng
|
H361d
H410
|
|
M = 1 000
M = 1 000 “
|
|
„613-208-00-7
|
imazamoks (ISO);
(RS)-2-(4-izopropil-4-metil-5-okso-2-imidazolin-2-il)-5-metoksimetilnikotinska kislina
|
–
|
114311-32-9
|
Repr. 2
Aquatic Acute 1
Aquatic Chronic 1
|
H361d
H400
H410
|
GHS08
GHS09
Wng
|
H361d
H410
|
|
M = 10
M = 10“
|
|
„613-267-00-9
|
tiametoksam (ISO);
3-(2-kloro-tiazol-5-ilmetil)-5-metil[1,3,5]oksadiazinan-4-iliden-N-nitroamin
|
428-650-4
|
153719-23-4
|
Repr. 2
Acute Tox. 4
Aquatic Acute 1
Aquatic Chronic 1
|
H361fd
H302
H400
H410
|
GHS07
GHS08
GHS09
Wng
|
H361fd
H302
H410
|
|
oralno: ATE = 780 mg/kg tt
M = 10
M = 10“
|
|
„613-282-00-0
|
tritikonazol (ISO);
(RS)-(E)-5-(4-klorobenziliden)-2,2-dimetil-1-(1H-1,2,4-triazol-1-metil)ciklopentanol
|
–
|
138182-18-0
|
Repr. 2
STOT RE 2
Aquatic Acute 1
Aquatic Chronic 1
|
H361f
H373
H400
H410
|
GHS08
GHS09
Wng
|
H361f
H373
H410
|
|
M = 1
M = 1“
|
|
„616-032-00-9
|
diflufenikan (ISO);
N-(2,4-difluorofenil)-2-[3-(trifluorometil)fenoksi]-3-piridinkarboksamid; 2′,4′-difluoro-2-(α,α,α-trifluoro-m-toliloksi) nikotinanilid
|
–
|
83164-33-4
|
Aquatic Acute 1
Aquatic Chronic 1
|
H400
H410
|
GHS09
Wng
|
H410
|
|
M = 10 000
M = 1 000 “
|
|
„616-106-00-0
|
fenmedifam (ISO); metil 3-(3-metilkarbaniloiloksi)karbanilat
|
237-199-0
|
13684-63-4
|
Aquatic Acute 1
Aquatic Chronic 1
|
H400
H410
|
GHS09
Wng
|
H410
|
|
M = 10
M = 10“
|
|
„616-113-00-9
|
desmedifam (ISO);
etil 3-fenilkarbamoiloksifenilkarbamat
|
237-198-5
|
13684-56-5
|
Repr. 2
Aquatic Acute 1
Aquatic Chronic 1
|
H361d
H400
H410
|
GHS08
GHS09
Wng
|
H361d
H410
|
|
M = 10
M = 10“
|
|